Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FERM and PDZ domain-containing protein 3 (FRMPD3) is a cytoplasmic protein encoded by the FRMPD3 gene and characterized by the presence of a PDZ domain at the N-terminus and a FERM domain. The PDZ domain mediates specific protein-protein interactions by binding to other proteins’ C-terminal peptides, while the FERM domain is typically associated with the plasma membrane and the actin cytoskeleton. FRMPD3 is involved in cellular signal transduction and the structural organization of protein complexes at the membrane. It is considered an adaptor or scaffold protein rather than a classical therapeutic target such as a receptor, enzyme, or ion channel. Although some FRMPD family members, such as FRMPD4, are implicated in synaptic function and intellectual disability in related studies, there is limited evidence directly linking FRMPD3 to disease or pharmacological modulation[1][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FERM and PDZ domain-containing protein 3 (FRMPD3).